Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

sirolimus-loaded polymeric nanoparticles

Based on

1 Patents
2013 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(ethylene glycol)-block-polylactide copolymer

PLA-PEG
Type Polymer
Formula
Role binder
2

rapamycin

sirolimus
Type Single Compound
Formula C51H79NO13
Role fillers

Properties

General physical and chemical properties

Property Value Source
drug release

More information available to subscribers only.

Or, view sample content

Applications

Area Application Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Method Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • poly(ethylene glycol)-block-polylactide copolymer
  • rapamycin
  1. 1GBxOhNUWjWyl6LwfDn9v6FDBJuRUeWLgT7y1vPZtKTPpBvpT62gIs2L2u
  2. oEegQU3cusxqOtA
Product

sirolimus-loaded polymeric nanoparticles

Method 2

Type: Physical formation
Source:
Starting materials
  • poly(ethylene glycol)-block-polylactide copolymer
  • rapamycin
  1. u3RonwyW2vC91GcBiH2snviObJGhxrkFvhjbEUHr8lfLtXFqQVOyJdW3f7
  2. 8fVsUHTlXlFneNR
Product

sirolimus-loaded polymeric nanoparticles

Method 3

Type: Physical formation
Source:
Starting materials
  • poly(ethylene glycol)-block-polylactide copolymer
  • rapamycin
  1. UJRtz0kluZyydFYCElwuZ1Dj4YKSq8AhYm2IklOSz9hhMj17eYKlKHB06a
  2. k6EverPk4O2FWBV
Product

sirolimus-loaded polymeric nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial